- Home
- MRUS vs ABR Comparison
MRUS vs ABR Comparison
Compare MRUS & ABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRUS
- ABR
- Stock Information
- Founded
- MRUS 2003
- ABR 2003
- Country
- MRUS Netherlands
- ABR United States
- Employees
- MRUS N/A
- ABR N/A
- Industry
- MRUS Biotechnology: Pharmaceutical Preparations
- ABR Real Estate Investment Trusts
- Sector
- MRUS Health Care
- ABR Real Estate
- Exchange
- MRUS Nasdaq
- ABR Nasdaq
- Market Cap
- MRUS 2.9B
- ABR 2.5B
- IPO Year
- MRUS 2016
- ABR 2004
- Fundamental
- Price
- MRUS $39.45
- ABR $13.79
- Analyst Decision
- MRUS Strong Buy
- ABR Hold
- Analyst Count
- MRUS 12
- ABR 6
- Target Price
- MRUS $87.92
- ABR $14.25
- AVG Volume (30 Days)
- MRUS 706.1K
- ABR 2.3M
- Earning Date
- MRUS 02-26-2025
- ABR 02-14-2025
- Dividend Yield
- MRUS N/A
- ABR 12.46%
- EPS Growth
- MRUS N/A
- ABR N/A
- EPS
- MRUS N/A
- ABR 1.35
- Revenue
- MRUS $35,932,000.00
- ABR $650,354,000.00
- Revenue This Year
- MRUS N/A
- ABR N/A
- Revenue Next Year
- MRUS $57.37
- ABR N/A
- P/E Ratio
- MRUS N/A
- ABR $10.21
- Revenue Growth
- MRUS N/A
- ABR N/A
- 52 Week Low
- MRUS $31.62
- ABR $11.92
- 52 Week High
- MRUS $61.61
- ABR $15.94
- Technical
- Relative Strength Index (RSI)
- MRUS 38.07
- ABR 49.22
- Support Level
- MRUS $38.52
- ABR $12.71
- Resistance Level
- MRUS $47.75
- ABR $14.03
- Average True Range (ATR)
- MRUS 2.05
- ABR 0.30
- MACD
- MRUS -0.17
- ABR 0.04
- Stochastic Oscillator
- MRUS 16.83
- ABR 81.82
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
About ABR Arbor Realty Trust
Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment. The company is externally managed and advised by Arbor Commercial Mortgage, LLC.